p62/Sequestome1(SQSTM-1)-engineered Lactobacilli as biotherapeutic agents in Alzheimer's disease
收藏NIAID Data Ecosystem2026-04-25 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP225114
下载链接
链接失效反馈官方服务：
资源简介：
p62/Sequestome1/(SQSTM-1)-engineered Lactobacilli, in details L. lactis MG1363, were orally administered to transgenic Alzheimer's disease mice, namely 3xTg-AD. Upon four months treatment, effects on AD major hallmarks such as cognitive deficits, amyloid deposition, proteolysis dysfunctions, oxidation and inflammation were dissected. The ability to modulate microbiota composition was also evaluated.
创建时间：
2020-10-13
